##analysisDate=2017-11-08-12-47-05000
##analyzedBy=RingStudy Site G
##exportDate=2017-11-08-14-00-47000
##analysisName=Site G-Sample 9 Phase II
##workflowName=Oncomine Focus w2.1 - DNA and Fusions - Single Sample
##sampleNames=Site G-R3-Sample 9-F-D-R_v1:Site G-R3-Sample 9-F-D-R_RNA_v1
##reference=hg19
##variantGroup=DEFAULT
##filterChain=Site D_NoRef
##searchText=
##chromosome=All
##totalVariantCount=826
##filterInCount=14
##filteredOutCount=812
##hiddenVariantCount=0
Locus	Genotype	Ref	Type	No Call Reason	Genes	Location	Length	Oncomine Variant Class	Oncomine Gene Class	Copy Number	CytoBand	Info	Variant ID	Variant Name	% Frequency	Amino Acid Change	Read Counts	Coverage	Allele Ratio	CNV Confidence	Detection	3'/5' Imbalance	COSMIC/NCBI	Read Counts Per Million	Strand	Exon	Transcript	Coding	Variant Effect	PhyloP	SIFT	Grantham	PolyPhen	PFAM	dbSNP	DGV	MAF	EMAF	AMAF	GMAF	UCSC Common SNPs	Gene Ontology	DrugBank	ClinVar	p-value	Phred QUAL Score	Allele Coverage	CNV Precision	Ref+/Ref-/Var+/Var-	Homopolymer Length	Tiles
chr1:11184624	A/C	A	SNV		MTOR	exonic	1								31.11	p.Val2198Gly		1996	A=0.6889, C=0.3111		Present				-	47	NM_004958.3	c.6593T>G	missense	2.23	0.01	109.0	1.0	FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase								ATP binding,Golgi apparatus,Golgi membrane,PML body,RNA polymerase III type 1 promoter DNA binding,RNA polymerase III type 2 promoter DNA binding,RNA polymerase III type 3 promoter DNA binding,T cell costimulation,TFIIIC-class transcription factor binding,TOR signaling cascade,TORC1 complex,TORC2 complex,cell growth,cellular response to hypoxia,cellular response to nutrient levels,cytoplasm,cytosol,dendrite,endomembrane system,endoplasmic reticulum,endoplasmic reticulum membrane,fibroblast growth factor receptor signaling pathway,germ cell development,growth,insulin receptor signaling pathway,kinase activity,lysosome,mTOR-FKBP12-rapamycin complex,membrane,mitochondrial outer membrane,mitochondrion,negative regulation of NFAT protein import into nucleus,negative regulation of autophagy,negative regulation of cell size,negative regulation of macroautophagy,nerve growth factor receptor signaling pathway,neuronal cell body,nucleotide binding,nucleus,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,phosphatidylinositol 3-kinase complex,phosphatidylinositol-mediated signaling,phosphoprotein binding,phosphorylation,phosphotransferase activity, alcohol group as acceptor,positive regulation of actin filament polymerization,positive regulation of endothelial cell proliferation,positive regulation of lamellipodium assembly,positive regulation of lipid biosynthetic process,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of protein kinase B signaling cascade,positive regulation of protein phosphorylation,positive regulation of stress fiber assembly,positive regulation of transcription from RNA polymerase III promoter,positive regulation of translation,protein autophosphorylation,protein binding,protein catabolic process,protein domain specific binding,protein phosphorylation,protein serine/threonine kinase activity,regulation of Rac GTPase activity,regulation of actin cytoskeleton organization,regulation of carbohydrate metabolic process,regulation of carbohydrate utilization,regulation of fatty acid beta-oxidation,regulation of glycogen biosynthetic process,regulation of protein kinase activity,regulation of response to food,response to amino acid stimulus,response to insulin stimulus,response to nutrient,ribosome binding,ruffle organization,signal transduction,soluble fraction	Everolimus,Pimecrolimus,Sirolimus,Temsirolimus		0.00001	3306.98	A=1375, C=621		A=799/576, C=354/267	1	
chr1:65310489	T/C	T	SNV		JAK1	exonic	1								36.06	p.(=)		1991	T=0.6394, C=0.3606		Present				-	16	NM_002227.2	c.2199A>G	synonymous	-4.13				Protein kinase domain,Protein tyrosine kinase	rs2230588		0.352 (ref)	0.2323	0.418	0.3492	YES	ATP binding,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,growth hormone receptor binding,interferon-gamma-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,membrane,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,protein binding,protein phosphorylation,protein tyrosine kinase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,response to antibiotic,type I interferon-mediated signaling pathway	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile		0.00001	4319.11	T=1273, C=718		T=730/543, C=403/315	1	
chr2:29416366	G/C	G	SNV		ALK	exonic	1								52.08	p.Asp1529Glu		1997	G=0.4792, C=0.5208		Present				-	29	NM_004304.4	c.4587C>G	missense	-1.46	1.0	45.0	0.0	MAM domain,Protein kinase domain,Protein tyrosine kinase	rs1881421		0.435 (ref)	0.3438	0.3915	0.4335	YES	ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	8252.29	G=957, C=1040		G=373/584, C=392/648	1	
chr2:29416572	C/C	T	SNV		ALK	exonic	1								100.00	p.Ile1461Val		1994	T=0.0, C=1.0		Present				-	29	NM_004304.4	c.4381A>G	missense	-0.25	1.0	29.0	0.0	MAM domain,Protein kinase domain,Protein tyrosine kinase	rs1670283		0.007 (ref)	3.0E-4	0.0279	0.0097		ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	26800.9	T=0, C=1994		T=0/0, C=1001/993	1	
chr2:29551347, chr2:29430138			ASSAYS_5P_3P		ALK								ALK.5p_NM_004304.4.e5e6,ALK.3p_NM_004304.4.e23e24				13560,3839				Absent, LOW_5P_3P_IMBALANCE_SCORE	-0.0816		9.8835e-08,2.7981e-08																						0.0					
chr4:1801137	TGGCCCCAG/TGGTGCCCCAG	TGGGGCCCCAG	INDEL,SNV		FGFR3	exonic, exonic	2								TGCCCCAG=0.00, TGGCCCCAG=94.72, TGGGGCCCAG=0.00, TGGGGCCCAGC=0.00, TGGTGCCCCAG=5.08	p.Gly90Val, p.Gly90fs		1970	TGGGGCCCCAG=0.002, TGCCCCAG=0.0, TGGCCCCAG=0.9472, TGGGGCCCAG=0.0, TGGGGCCCAGC=0.0, TGGTGCCCCAG=0.0508		Present				+	3	NM_000142.4, NM_000142.4	c.269G>T, c.269_270delGG	missense, frameshiftDeletion	0.52,1.91,1.91,1.91,-0.03,1.91,0.71,-1.06,1.91,-0.19,1.91	0.52	109.0	0.036	Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs144995231							ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development	Palifermin,Pazopanib		0.00001	25593.2	TGGGGCCCCAG=4, TGCCCCAG=0, TGGCCCCAG=1866, TGGGGCCCAG=0, TGGGGCCCAGC=0, TGGTGCCCCAG=100		TGGGGCCCCAG=0/4, TGCCCCAG=0/0, TGGCCCCAG=899/967, TGGGGCCCAG=0/0, TGGGGCCCAGC=0/0, TGGTGCCCCAG=0/100	4,4,4,4,4	
chr4:1807894	A/A	G	SNV		FGFR3	exonic	1								100.00	p.(=)		1990	G=0.0, A=1.0		Present				+	14	NM_000142.4	c.1953G>A	synonymous	0.05				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs7688609		0.042 (ref)	8.0E-4	0.131	0.0449	YES	ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development	Palifermin,Pazopanib		0.00001	26695.1	G=0, A=1990		G=0/0, A=1168/822	1	
chr4:55141055	G/G	A	SNV		PDGFRA	exonic	1								100.00	p.(=)		1994	A=0.0, G=1.0		Present				+	12	NM_006206.4	c.1701A>G	synonymous	-5.31				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs121913270,rs121913271,rs1873778		0.037 (ref)	0.0015	0.1185	0.0411	YES	ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing	Becaplermin,Imatinib,Pazopanib,Sunitinib		0.00001	26808.4	A=0, G=1994		A=0/0, G=1049/945	1	
chr5:176517985	A/G	A	SNV		FGFR4	exonic	1								27.52	p.(=)		1312	A=0.7248, G=0.2752		Present				+	5	NM_213647.1	c.483A>G	synonymous	-3.74				Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,alveolar secondary septum development,cell migration,cell-cell junction,cytoplasm,endoplasmic reticulum,endosome,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor 2 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,glucose homeostasis,heparin binding,insulin receptor signaling pathway,integral to plasma membrane,lung development,nucleolus,nucleotide binding,nucleus,organ induction,peptidyl-tyrosine phosphorylation,phosphate ion homeostasis,plasma membrane,positive regulation of DNA biosynthetic process,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell proliferation,positive regulation of metalloenzyme activity,positive regulation of proteolysis,protein autophosphorylation,protein tyrosine kinase activity,receptor activity,regulation of bile acid biosynthetic process,regulation of cholesterol homeostasis,regulation of extracellular matrix disassembly,regulation of lipid metabolic process	Palifermin		0.00001	1727.88	A=951, G=361		A=478/473, G=347/14	1	
chr7:116411708 - chr7:116414934			FUSION		MET(13) - MET(15)			Fusion	Gain-of-function				MET-MET.M13M15				166				Present			1.2099e-09		13																				0.0					
chr7:140453136	ACTG/TCTG	ACTG	SNV		BRAF	exonic	1	Hotspot	Gain-of-function			HS	COSM26504;COSM6137;COSM18443;COSM476;COSM1583011;COSM474;COSM249889;COSM473;COSM1127;COSM1735763		ACTGTAGCTAGACCAAAATCTG=0.00, CCTG=0.00, GCTG=0.00, TCTG=66.58, CGTG=0.00, CTTG=0.00, TGTG=0.00, TTTG=0.00, CTCG=0.00, TTTA=0.00	p.Val600Glu		1975	ACTG=0.3342, ACTGTAGCTAGACCAAAATCTG=0.0, CCTG=0.0, GCTG=0.0, TCTG=0.6658, CGTG=0.0, CTTG=0.0, TGTG=0.0, TTTG=0.0, CTCG=0.0, TTTA=0.0		Present				-	15	NM_004333.4	c.1799T>A	missense	2.17,2.69,2.17,2.69	0.0	121.0	0.971	C1-like domain,Phorbol esters/diacylglycerol binding domain (C1 domain),Protein kinase domain,Protein tyrosine kinase,Raf-like Ras-binding domain	rs113488022,rs121913227,rs121913374,rs121913375,rs121913377,rs121913378							ATP binding,MAP kinase kinase kinase activity,activation of MAPKK activity,anti-apoptosis,cytoplasm,cytosol,metal ion binding,mitogen-activated protein kinase kinase binding,negative regulation of apoptotic process,negative regulation of neuron apoptosis,nerve growth factor receptor signaling pathway,nucleotide binding,nucleus,organ morphogenesis,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of peptidyl-serine phosphorylation,protein binding,protein heterodimerization activity,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,receptor signaling protein activity,response to cAMP,response to peptide hormone stimulus,small GTPase mediated signal transduction,soluble fraction,synaptic transmission,synaptosome	(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime,N-{2,4-difluoro-3-(5-pyridin-3-yl-1H-pyrrolo2,3-bpyridin-3-yl)carbonylphenyl}ethanesulfonamide,N-{3-(5-chloro-1H-pyrrolo2,3-bpyridin-3-yl)carbonyl-2,4-difluorophenyl}propane-1-sulfonamide,Sorafenib	other,pathogenic	0.00001	13832.3	ACTG=660, ACTGTAGCTAGACCAAAATCTG=0, CCTG=0, GCTG=0, TCTG=1315, CGTG=0, CTTG=0, TGTG=0, TTTG=0, CTCG=0, TTTA=0		ACTG=320/340, ACTGTAGCTAGACCAAAATCTG=0/0, CCTG=0/0, GCTG=0/0, TCTG=689/626, CGTG=0/0, CTTG=0/0, TGTG=0/0, TTTG=0/0, CTCG=0/0, TTTA=0/0	1,1,1,1,1,1,1,1,1,1	
chr9:80412471	G/A	G	SNV		GNAQ	exonic	1								80.14	p.(=)		1994	G=0.1986, A=0.8014		Present				-	4	NM_002072.4	c.570C>T	synonymous	0.81				G-protein alpha subunit								G-protein beta/gamma-subunit complex binding,G-protein coupled receptor binding,G-protein coupled receptor signaling pathway,GTP binding,GTP catabolic process,GTPase activator activity,GTPase activity,activation of adenylate cyclase activity by G-protein signaling pathway,activation of phospholipase C activity,activation of phospholipase C activity by dopamine receptor signaling pathway,behavior,blood coagulation,cytoplasm,developmental pigmentation,embryonic digit morphogenesis,extrinsic to internal side of plasma membrane,forebrain neuron development,glutamate signaling pathway,guanyl nucleotide binding,guanyl-nucleotide exchange factor activity,heart development,heterotrimeric G-protein complex,membrane fraction,metal ion binding,negative regulation of protein kinase activity,neuron remodeling,nucleotide binding,phospholipase C activity,plasma membrane,platelet activation,positive regulation of GTPase activity,post-embryonic development,protein ADP-ribosylation,protein binding,protein stabilization,regulation of action potential,regulation of catenin import into nucleus,regulation of melanocyte differentiation,signal transducer activity,skeletal system development			0.00001	17368.9	G=396, A=1598		G=223/173, A=937/661	1	
chr10:43606730, chr10:43622086			ASSAYS_5P_3P		RET								RET.5p_NM_020975.4.e6e7,RET.3p_NM_020975.4.e18e19				1,474				Absent, LOW_5P_3P_IMBALANCE_SCORE	0.004		7.2887e-12,3.4548e-09																						0.0					
chr10:43613843	T/T	G	SNV		RET	exonic	1								100.00	p.(=)		1996	G=0.0, T=1.0		Present				+	13	NM_020975.4	c.2307G>T	synonymous	1.34				Cadherin domain,Protein kinase domain,Protein tyrosine kinase	rs1800861		0.277 (ref)	0.2347	0.1246	0.1974	YES	ATP binding,MAPKKK cascade,calcium ion binding,cellular response to retinoic acid,embryonic epithelial tube formation,endosome membrane,enteric nervous system development,homophilic cell adhesion,induction of apoptosis,integral to membrane,integral to plasma membrane,membrane,membrane protein proteolysis,nervous system development,neural crest cell migration,neuron maturation,nucleotide binding,positive regulation of cell adhesion mediated by integrin,positive regulation of cell migration,positive regulation of metanephric glomerulus development,positive regulation of neuron projection development,positive regulation of transcription, DNA-dependent,posterior midgut development,protein binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell adhesion,response to pain,signal transduction,transmembrane receptor protein tyrosine kinase activity,ureteric bud development	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,4-BROMO-2-FLUORO-N-(4E)-6-METHOXY-7-(1-METHYLPIPERIDIN-4-YL)METHOXYQUINAZOLIN-4(1H)-YLIDENEANILINE,Imatinib	untested	0.00001	26919.6	G=0, T=1996		G=0/0, T=999/997	1	
